A Quiet Word:
Lobbying, Crony Capitalism
and Broken Politics in Britain

$3,120,000 spent on lobbying in US, covers roughly through Q2, 2014 [2]

UK government doesn't require disclosure of lobbying spend in UK.

April 2013

  • Dr James Shannon, Chief Medical Officer, GlaxoSmithKline gave evidence related to clinical trials on 22 Apr. [26]

April 2012

Dec 2011 - Feb 2012

Jun 2011 - Aug 2011

Sep 2010 - Nov 2010

September 2011

Dept. for Business, Innovation and Skills
  • GSK met with Stephen Green, Minister of State, to discuss trade and investment, along with 41 others. [4]
  • Glaxo Smith Kline met with David Willetts, Minister of State, to discuss science, along with 26 others. [4]
Cabinet Office
  • GSK met with Oliver Letwin, Minister for Government Policy, to discuss Queen Elizabeth Prize for Engineering, along with 11 others. [3]
Dept. of Health
  • Glaxo Smith Kline met with David Nicholson, NHS Chief Executive, to discuss Relationship between NHS and Pharma Industry. [5]

July 2011

Dept. for Business, Innovation and Skills
  • GlaxoSmithKline met with David Willetts, Minister of State, to discuss science and business, along with 9 others. [4]
  • Glaxo Smith Klein met with Stephen Green, Minister of State, to discuss trade and investment, along with 12 others. [4]
Her Majesty's Treasury

June 2011

Her Majesty's Treasury

May 2011

Her Majesty's Treasury
  • GSK met with George Osborne, Chancellor of the Exchequer, for general discussion, along with 11 others. [8]
Prime Minister's Office
  • GSK met with David Cameron, Prime Minister, to discuss business issues, along with 11 others. [9]

April 2011

Dept. for Business, Innovation and Skills
  • GlaxoSmithKline met with David Willetts, Minister of State, to discuss science, along with 13 others. [7]
Her Majesty's Treasury
  • GlaxoSmithKline met with David Gauke, Exchequer Secretary to the Treasury, for Business Competitiveness Forum, along with 11 others. [8]

March 2011

Her Majesty's Treasury

February 2011

Dept. for Business, Innovation and Skills
  • GlaxoSmithKline met with David Willetts, Minister of State, to discuss science, along with 13 others. [10]
Prime Minister's Office
  • GSK met with David Cameron, Prime Minister, to discuss security issues, along with 12 others. [13]

January 2011

Dept. for Business, Innovation and Skills
Dept. of Health
  • GlaxoSmithKline met with Frederick Curzon, Parliamentary Under-Secretary of State, to discuss Feedback session. [11]

December 2010

Dept. for Business, Innovation and Skills
  • GlaxoSmithKline met with David Willetts, Minister of State, to discuss science, along with 9 others. [15]
Dept. for International Development
  • GlaxoSmithKline UK met with Stephen O'Brien, Parliamentary under Secretary of State, for discussion on access to medicines in developing countries. [16]
Her Majesty's Treasury
  • GlaxoSmithKline met with David Gauke, Exchequer Secretary to the Treasury, to discuss Business Tax Forum for Competitiveness, along with 11 others. [17]

November 2010

Her Majesty's Treasury
  • GlaxoSmithKline met with David Gauke, Exchequer Secretary to the Treasury, for update meeting. [17]
Prime Minister's Office
  • GlaxoSmithKline met with Jeremy Heywood, Permanent Secretary, to discuss Dinner meeting – UK business environment. [14]

October 2010

Dept. for Business, Innovation and Skills
  • GlaxoSmithKline met with Vincent Cable, Secretary of State for Business, Innovation and Skills, to discuss business, along with 17 others. [15]

September 2010

Dept. for Business, Innovation and Skills
  • GlaxoSmithKline met with Judith Wilcox, Parliamentary Under Secretary of State, to discuss Intellectual Property. [18]
Her Majesty's Treasury
  • GlaxoSmithKline met with David Gauke, Exchequer Secretary to the Treasury, for Business round-table, along with 9 others. [19]

August 2010

Dept. for Business, Innovation and Skills
  • GSK met with David Willetts, Minister of State, to discuss science, along with 18 others. [18]

July 2010

Her Majesty's Treasury
  • Glaxo Smith Kline met with George Osborne, Chancellor of the Exchequer, for general meeting. [20]

June 2010

Her Majesty's Treasury
  • Glaxo Smith Kline met with George Osborne, Chancellor of the Exchequer, for general meeting. [20]

This profile was compiled by Who's Lobbying and is about GlaxoSmithKline.

This page is not endorsed by or affiliated with GlaxoSmithKline.

Problem with this information?

Please let us know by emailing: